Learn more

HANMI HOLDINGS CO LTD

Overview
  • Total Patents
    242
About

HANMI HOLDINGS CO LTD has a total of 242 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Republic of Korea, China and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ACERTA PHARMA BV, KHANMI SAJENS KO LTD and CADILA PHARMACEUTICALS LTD.

Patent filings per year

Chart showing HANMI HOLDINGS CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lee Gwan Sun 79
#2 Kwon Se Chang 59
#3 Park Jae Hyun 45
#4 Woo Jong Soo 33
#5 Kim Kyeong Soo 33
#6 Song Dae Hae 27
#7 Kim Yong Il 26
#8 Yim Ho Taek 24
#9 Jung Sung Youb 23
#10 Kim Maeng Sup 23

Latest patents

Publication Filing date Title
KR20120010146A Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity
CN102947316A Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
WO2011122923A2 Long-acting interferon beta formulation using immunoglobulin fragment
WO2011122921A2 An insulin conjugate using an immunoglobulin fragment
AR081755A1 FORMULATION OF PROLONGED ACTION OF THE FOLICULES STIMULATING HORMONE WHERE AN IMMUNOGLOBULIN FRAGMENT, PREPARATION METHOD AND METHOD TO TREAT A SUBJECT SUFFERING A REPRODUCTIVE DISORDER ARE USED
KR20110085917A Liquid formulations for long-acting g-csf conjugate
KR20120014736A Method for analyzing aspirin in plasma with liquid chromatography-mass spectrometry
KR20120007182A A liquid formulation of long acting human growth hormone conjugate
KR20120002129A A FACTOR VIIa COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT
KR20110135685A Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
KR20110126020A Bilayered pharmaceutical composition of hmg-coa reductase inhibitor and irbesartan
KR20110134209A An single chain-insulin analog complex using an immunoglobulin fragment
KR20110134210A Insulin derivative drug conjugate using an immunoglobulin fragment
KR20110124931A Service method for information of medicine
KR20110118489A Nonslip blister film sheet and press-through package comprising the same
KR20110116347A Management system and method for access authority
KR20110115369A Apparatus for detecting abmormal product
KR20110113946A Goods selecting apparatus and its method
KR20110114073A Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent
KR20110112985A Capsule temporary-filling tray, apparatus and method for capsule filling